Synthetic dimyristoylphosphatidylcholine liposomes assimilating into high-density lipoprotein promote regression of atherosclerotic lesions in cholesterol-fed rabbits

Experimental Biology and Medicine

Volumn 235, Issue 10, 2010, Pages 1194-1203

  Simon Cho, Byung H ^a,b   Park, Jeong Ro ^b,c   Nakamura, Manabu T ^b   Odintsov, Boris M ^b   Wallig, Matthew A ^b   Chung, Byung Hong ^d  

^a Harlan E Moore Heart Research Foundation   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c Sunchon National University   (South Korea)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Atherosclerotic lesions; Dimyristoylphosphatidylcholine; High density lipoprotein; Liposomes; Plaque regression

Indexed keywords

DIMYRISTOYLPHOSPHATIDYLCHOLINE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; CHOLESTEROL; CHOLESTEROL INTAKE; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; EGG; IN VIVO STUDY; LIPID ANALYSIS; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RABBIT; REMISSION; SOYBEAN; ADMINISTRATION AND DOSAGE; ANIMAL; AORTA; BLOOD; CHOLESTEROL INTAKE; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; PATHOLOGY;

ORYCTOLAGUS CUNICULUS;

ANIMALS; AORTA; ATHEROSCLEROSIS; CHOLESTEROL; CHOLESTEROL, DIETARY; DIMYRISTOYLPHOSPHATIDYLCHOLINE; IN VITRO TECHNIQUES; INFUSIONS, INTRAVENOUS; LIPOPROTEINS, HDL; LIPOSOMES; MALE; RABBITS;

EID: 77957825383     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2010.009320     Document Type: Article

References (42)

1. Goldon T, Castelli WP, Hjortland M, Kannel WB, Dawber T. High-density lipoproteins as a protective factor against coronary heart disease. Am J Med 1977;62:707-14
2. Puchois P, Kandossi A, Fiebr O, Fournier JL, Bertland M, Koren E, Fruchard JC. Apolipoprotein A-I-containing lipoproteins in coronary heart disease. Atherosclerosis 1987;68:35-46
3. Goldon GJ, Probstfeld JL, Garrisom RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs JR, Bangdlwala S, Tyroler A. High density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8-15
4. Glomset JA. The plasma lecithin:cholesterol acyltransferase. J Lipid Res 1968;9:155-67
5. Franceschini G, Maderna P, Cirtori CR. Reverse cholesterol transport: physiology and pharmacology. Atherosclerosis 1981;88:99-107
6. Plump AS, Scott CJ, Breslow JL. Human apolipoprotein A-I gene expression increases high density lipoproteins and suppress atherosclerosis in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA 1994;91:9607-11
7. Badimon JJ, Badimon L, Fuster V. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbits. J Clin Invest 1990;85:1234-41
8. Miyazaki A, Sakuma S, Morikawa W, Takiue T, Miake F, Teano T, Sakai M, Hakamata H, Sakamoto TI, Naito M, Ruan Y, Takahashi K, Ohta T, Horiuchi S. Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 1995;15:1882-8
9. Milano mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content of apolipoprotein E-deficient mice; potential implications for acute plaque stabilization. Circulation 2001;103:3047-50
10. Nicholls SJ, Cutri B, Worthley SG, Kee P, Rye KA, Bao S, Barter PJ. Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis. Arterioscler Thromb Vasc Biol 2005;25:2416-21 (Pubitemid 41552664)
11. Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, McNamara JR, Kashyap ML, Hershman JM, Wexler LF, Rubins HB, for the VA-HIT Study Group. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA 2001;285:1585-91
12. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Portewr JG, Seilhamer JJ, Vaughan AM, Oram JF. The Tangier disease gene product ABCAI control the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 1999;104:R25-31
13. Ji Y, Jian B, Wang N, Sun Y, Llera-Moya MDL, Phillips MC, Rothblat GH, Swaney JB, Tall AR. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 1997;272:20982-5
14. Wang N, Lan W, Chen F, Matuura F, Tall AR. ATP-binding cassette transporter GI and G4 mediate cellular cholesterol efflux to high density lipoproteins. Proc Natl Acad Sci USA 2004;101:9774-9 (Pubitemid 38869312)
15. Fournier N, Llera-Moya MDL, Burkey BF, Swaney JB, Paterniti J, Moatti N, Atger V, Rothblat GH. Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apo A-I transgenic rats. J Lipid Res 1996;37:1709-17
16. Fournier N, Atger V, Cogny A, Vedie B, Giral P, Simmon A, Moatti N, Paul JL. Analysis of relationship between triglyceridemia and HDL-phospholipid concentrations: consequence on the efflux capacity of serum in the Fu5AH system. Atherosclerosis 2001;157:315-23
17. Jian B, Llera-Moya MDL, Royer L, Rothblat GH, Francone O, Swaney JB. Modification of the cholesterol efflux properties of human serum by enrichment with phospholipids. J Lipid Res 1997;38:734-44 (Pubitemid 27194924)
18. Pownall HJ. Detergent-mediated phospholipidation of plasma lipoproteins increases HDL cholesterolphilicity and cholesterol efflux via SR-BI. Biochemistry 2006;45:11514-22
19. Hsia SL, Duncan R, Schob AH, Chakko SC, Mulingtapang R, He JL, Perz GO. Serum levels of high density lipoprotein phospholipids correlate inversely with severity of angiographically defined coronary artery disease. Atherosclerosis 2002;215:469-73
20. Adams CMW, Adulla YH, Bayliss OB, Morgan RS. Modification of aortic atheroma and fatty liver in cholesterol-fed rabbits by intravenous injection of saturated and polyunsaturated lecithins. J Pathol Bacteriol 1967;94:77-87
21. Stafford WW, Day CE. Regression of atherosclerosis effected by intravenous phospholipid. Artery 1975;1:106-14
22. Rodrigueza WV, Klimuk SK, Prichard PH, Hope MJ. Cholesterol mobilization and regression of atheroma in cholesterol-fed rabbits induced by large unilamellar vesicles. Biochim Biophys Acta 1998;1368:306-20
23. Rodrigueza WV, Pritchard PH, Hope MJ. Influence of size and composition of cholesterol mobilizing properties of liposomes in vivo. Biochim Biophys Acta 1993;1153:9-19
24. Mohamad N, Hama S, Hough G, Fogelman AM. Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice. Circulation 2003;108:1735-9 (Pubitemid 37243663)
25. Davidson WS, Gillotte KL, Lund-Katz S, Johnson WJ, Rothblat GH, Phillips MC. The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol. J Biol Chem 1995;270:5882-90
26. Davidson WS, Lund-Katz S, Johnson WJ, Anatharamaiah AM, Palgunachari MN, Segrest JP, Rothblat GH, Phillips MC. The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoproteins. J Biol Chem 1994;269:22975-7982
27. Malberg FH, Glick J, Lund-Katz S, Rothblat GH. Influence of apolipoproteins AI, AII, and Cs on the metabolism of membrane and lysosomal cholesterol in macrophages. J Biol Chem 1991;266:19930-7
28. Chung BH, Franklin F, Liang P, Doran S, Cho BHS, Curcio CA. Phosphatidylcholine-rich acceptors, but not native HDL or its apolipoproteins, mobilize cholesterol from cholesterol-rich insoluble components of human atherosclerotic plaques. Biochim Biophys Acta 2005;1733:76-89
29. Tall AR, Hogan RV, Askinazi L, Small DM. Interaction of plasma high density lipoproteins with dimyristolylecithon multilamellar liposomes. Biochemistry 1978;17:322-6 (Pubitemid 8270220)
30. Pownall HJ, Massey JB, Kusserow SK, Gotto AM Jr. Kinetics of lipid-protein interactions: interaction of apolipoproteins A-I from human high density lipoproteins with phosphatidylcholine. Biochemistry 1978;17:1183-8
31. Chung BH, Segrest JP, Ray M, Brunzell J, Hokanson D, Krauss RM, Beaudrie K, Cone JT. Single vertical spin density gradient ultracentrifugation. Method Enzymol 1986;128:181-212
32. Folch J, Lees M, Sloane-Stranley CM. A simple method of isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226:497-509
33. Kishida T, Nagami H, Ogawa H, Ehihara K. The hypocholesterolemic effect of high amylase corn starch in rats is mediated by an enlarged bile acid pool and increased fecal bail acid excretion, not by fecal fermented products. J Nutr 2002;132:2519-24 (Pubitemid 35013228)
34. Rodrigueza WV, Mazany KD, Essenburg AD, Pape ME, Rea TJ, Bisgaier CL, Williams KJ. Large versus small unilamellar vesicles mediate reverse cholesterol transport in vivo into two distinct hepatic metabolic pools: implications for the treatment of atherosclerosis. Arterioscler Thromb Vasc Biol 1997;17:2132-9
35. Williams KJ, Werth VP, Wolff JA. Intravenously administered lecithin liposomes: a synthetic antiatherogenic lipid particle. Perspect Biol and Med 1984;27:417-31
36. Williams KJ, Scanu AM. Uptake of endogenous cholesterol by a synthetic lipoprotein. Biochim Biophys Acta 1986;875:183-94
37. Tall AR, Green PHR. Incorporation of phosphatidylcholine into spherical and discoidal lipoproteins during incubation of egg phosphatidylcholine vesicles with isolated high density lipoproteins or with plasma. J Biol Chem 1981;256:2035-44
38. Hassan HH, Blain S, Boucher B, Denis M, Krimbou L, Genest G. Structural modification of plasma HDL by phopholipids promote efficient ABCAI-mediated cholesterol efflux. J Lipid Res 2005;46:1457-65 (Pubitemid 43109810)
39. Gelissen IC, Harris M, Rye KA, Quinn C, Brown AJ, Kockx M, Cartland S, Packianathan M, Kritharides L, Jessup W. ABCAI and ABCGI synergize to mediate cholesterol export to apo A-I. Arterioscler Thromb Vasc Biol. 2006;26:534-40
40. Yancey PG, Llera-Moya MDL, Swanarkar S, Monzo P, Klein SM, Connelly MA, Johnson WJ, Rothblat GH. HDL phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular cholesterol mediated by scavenger receptor-BI (SR-BI). J Biol Chem 2000;275:36569-604
41. Chung BH, Franklin F, Cho BHS, Segrest JP, Hart K, Darnell B. Potencies of lipoproteins in fasting and postprandial plasma to accept additional cholesterol molecules released from cell membranes. Atheroscler Thromb Vasc Biol 1998;18:1217-30
42. Rothblat GH, Llera-Moya MDL, Atger A, Kellner-Weibel G, William DL, Philips MC. Cell cholesterol efflux: integration of old and new observation provides new insights. J Lipid Res 1999;40:781-96